Management of high-risk newly diagnosed MM

Meletios Dimopoulos, MD, University of Athens School of Medicine, Athens, Greece, calls attention to high-risk newly diagnosed multiple myeloma patients as an unmet population and highlights the need for more clinical studies into viable treatment options for this group. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).